Modern Brand, Vintage Ad

TikTok's child-privacy allegations and youth-harm lawsuits meet the Joe Camel precedent in a three-card mid-century satire.

OxyContin. 3 cards. Late-1950s clinical pharmaceutical lithograph style. Low abuse potential. High settlement value.

Roundup. 3 cards. Mid-1950s Better Homes & Gardens style. Now classified Group 2A. Probably carcinogenic. Probably fine.

Red Bull. 3 cards. Late 1950s Saturday Evening Post style. A vintage-ad reconstruction of the energy drink that promised wings, collected a $13M class-action settlement for unsubstantiated performance claims, got banned across France, Denmark, and Norway, and exploited the FDA dietary supplement loophole for decades. With Benzedrine pep pills and cocaine-era Coca-Cola as historical precedents.

Peloton. 3 cards. Early 1960s Ladies Home Journal style. Because nothing says 'I love you' like an implied diagnosis.

Bitcoin. 3 cards. Late 1950s financial prospectus style. No keys, no vault — just trust us with everything.

Uber Eats. 3 cards. Early 1960s Good Housekeeping style. Surge prices may apply. Dignity not included.

Episode 36. A 3-card late 1950s/early 1960s vintage ad reconstruction for Diet Coke / aspartame. Card A: slim housewife in powder-blue sheath dress, physician inset, lemon yellow background — headline 'GROUP 2B — APPROVED FOR DAILY USE', tagline names formaldehyde and WHO lobbying, body line 'IARC called it. Coca-Cola called their lobbyists first.' Card B: Ladies Home Journal editorial spread pivoting from 1950s diet culture (Tab, Sweet'N Low) to IARC Group 2B classification July 2023, same-day Coca-Cola lobbying, JECFA ADI. Card C: two-column precedents — Saccharin/Sweet'N Low (FDA proposed ban 1977, congressional moratorium, Calorie Control Council) and Tab/Cyclamate (Coca-Cola 1963–2020; cyclamate banned FDA 1969). Closing: 'The sweetener changes. The science never quite catches up. The lobbying never stops.'

Episode 35. A 3-card 1950s Good Housekeeping-style reconstruction of TikTok as the digital babysitter that never sleeps. Card A: 1950s mother + child, Spencerian headline 'Free Your Hands — He's Collecting Theirs,' physician badge 'Endorsed by No One Who Read The TOS.' Card B pivots to present: FTC $5.7M COPPA settlement (2019), Senate Judiciary hearing + 41 AGs (Jan 2024), algorithm routing minors to harmful content in 6 minutes, Montana ban + federal PAFACA act (2024–25), ByteDance data access. Card C names the precedents: Joe Camel (R.J. Reynolds, 1988–1997, FTC withdrawal) and FTC Kid-Vid hearings (1978–1981, Children's Television Act 1990). Closing: 'The medium changes. The targeting of children never does.'

Episode 34. A 3-card late-1950s/early-1960s Philip Morris IQOS reconstruction. Card A: sleek executive + physician, headline 'SMOKE-FREE. MARLBORO OPTIONAL.' / body 'Science moves forward. Revenue stays right where it was.' Card B pivots hard to present: FDA 2019 authorization + 2022 partial risk-claim revocation, PMI >50% combustible revenue, WHO FCTC exclusion of the Foundation for a Smoke-Free World as an industry front, CDC youth vaping data 2017–2021. Card C names the precedents: Camel 'More Doctors' (R.J. Reynolds, 1946–1952, FTC withdrawal 1955) and Marlboro Lights low-tar fraud (1960s–1990s, MSA 1998). Closes: 'The cigarette changes shape. The claim never does.' Ep 31 callback: same company.

Episode 33. A 3-card 1950s-era Johnson & Johnson talc baby powder reconstruction. Card A: smiling mother + laughing baby, Spencerian headline names the asbestos cover-up while playing the vintage ad straight. Card B pivots hard to the present: J&J knew since at least 1971 its talc tested positive for asbestos (Reuters/NYT 2018-19), $8.9B LTL bankruptcy settlement attempt rejected by courts (2023), ~40,000 lawsuits, FDA talc ban effective Jan 2024. Card C names the precedents: Nestlé formula hospital-seeding (WHO Code violated 1981, boycott still active 2024) and Lysol feminine hygiene 1930s-40s (carbolic acid, AMA condemned). Closes: 'The powder changes. The memos never do.'

A 3-card 1950s–60s Coca-Cola reconstruction. Card A: housewife + physician in bold red-and-cream palette, headline lands the aspartame/lobbying joke while playing the vintage ad straight. Card B pivots hard to the present: IARC classified aspartame as Group 2B carcinogen (July 2023), Coca-Cola lobbied WHO same day; the Global Energy Balance Network front ($1.5M, 2014–15) mirrors the sugar-doubt playbook exposed by the NYT. Card C names the precedents: Sugar Research Foundation 1967 Harvard payments (UCSF 2016) and Tab/saccharin congressional lobbying 1977. The sweetener changes. The science never quite catches up.